Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: A randomized clinical trial - MD Linx

Submitted by Anonymous (not verified) on Mon, 06/10/2019 - 11:05

Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: A randomized clinical trial  MD LinxThrough a phase 3, multicenter, double-blind, randomized withdrawal study of 297 adult patients with treatment-resistant depression (TRD) in stable remission ...